WANECAM sub-study analysis published today in The Lancet Infectious Diseases Interim data from a clinical trial led by the West African Network for Clinical Trials of Antimalarial Drugs (WANECAM) published online in The Lancet Infectious Diseases today, supports the safety and efficacy of the artemisinin-based combination therapy (ACT) Pyramax® (pyronaridine-artesunate) when used for the re-treatment […]
In this honest and revealing interview, Professor Agrégé Abdoulaye Djimdé explains his work conducting clinical trials of antimalarial drugs in West Africa, and the progress being made towards extending malarial research on the continent, for the continent. MARTIN LUTHER KING, JR famously said that injustice anywhere is a threat to justice everywhere In many ways, the […]
Malaria research in drug development, deployment and resistance New qPCR method will be used in WANECAM clinical trials of four ACTs. Click here for more.
The American Journal of Tropical Medicine & Hygiene published an article based on research conducted as part of the EDCTP-funded WANECAM clinical trial, led by Dr Abdoulaye Djimdé (University of Bamako, Mali). The authors concluded that in Mali there is currently no evidence of delayed parasite clearance following oral treatment for uncomplicated malaria with artesunate, a synthetic […]